logo
logo

The Israeli Start-Up Cvaid Raises $4 Million, Including Investment By Philips For Its Ai-Based Platform For Diagnosis Of Stroke

Feb 28, 2022•over 3 years ago

Amount Raised

$4 Million

Round Type

seed

Tel Aviv

Description

The Israeli digital health company CVAid Medical, which has developed a platform based on artificial intelligence for diagnosing and treating cerebrovascular accidents (CVAs, or strokes), has announced the completion of capital raising from Philips together with Sanara Capital. The Israeli Rad Biomed investment fund led the capital raising.

Company Information

Company

The Cv Aid

Location

Tel Aviv, Tel Aviv District, Israel

About

The Israeli digital health company CVAid Medical, which has developed a platform based on artificial intelligence for diagnosing and treating cerebrovascular accidents (CVAs, or strokes), has announced the completion of capital raising from Philips together with Sanara Capital. Until now, the company has carried out a seed capital raising of $500,000 from private investors, and additional support has been received as a grant from the Israel Innovation Authority. To date, the company has conducted clinical trials at a number of hospitals in Israel and Europe, and examined hundreds of patients.